Completed NA INTERVENTIONAL 2-arm NCT03541642

PrEP Communication Intervention for Female Clients of a Needle Exchange

Development and Pilot Testing of a PrEP Communication Intervention and Integration Into Existing HIV Testing Services for Female IV Drug Using Clients of a Needle Exchange

Sponsor: Temple University

Conditions HIV/AIDS

Interventions Basic Intervention Enhanced Intervention

Updated 9 times since 2018 Last updated: May 24, 2023 Started: Jun 1, 2018 Primary completion: Dec 17, 2021 Completion: Dec 17, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on HIV/AIDS, this trial is completed. The trial is conducted by Temple University and has accumulated 9 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2024 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Mar 2022 — Mar 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Mar 2020 — Jan 2021 [monthly]

Recruiting NA
Sep 2018 — Mar 2020 [monthly]

Recruiting NA
Aug 2018 — Sep 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Aug 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Temple University

Data source: Temple University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States